Hence, we report a novel Al18F-labeled ODAP-Urea-based PSMA probe, [18F]AlF-PSMA-137, the preclinical biological behavior was studied and clinical translation was successfully carried out to provide valuable information for further diagnosis and therapy of PCa. This evidence concerns the gene FOLH1 and posterior cortical atrophy.